Dr Helen Morris
Position: Senior Research Associate
Personal home page: http://www.medschl.cam.ac.uk/gppcru/index.php?option=com_content&view=article&id=202&Itemid=46&catid=17
PubMed journal articles - click here
In the Primary Care Unit I've managed and collaborated on a number of randomised controlled trials and other well-designed studies in the field of cancer and genetics in a primary care setting: 1) The GRAIDS (Genetic Risk Assessment on the Internet and Decision Support) Trial, CI Prof J Emery; 2) The MoleMate UK Trial: the management of suspicious pigmented lesions in primary care, CI Dr F Walter; 3) BEST (Barrett's Oesophagus Screening Trial), CI Dr R Fitzgerald; 4) The FAST Study: development and validation of a short family history screening tool for chronic disease prevention in primary care, CI Dr F Walter; 5) The SYMPTOM Study, part of the NIHR-funded Discovery programme, CI Dr F Walter (Programme lead Prof W Hamilton).
Symplectic Elements feed provided by Research Information, University of Cambridge
Walter FM, Prevost AT, Birt L, Grehan N, Restarick K, Morris HC, Sutton S, Rose P, Downing S and Emery JD. Development and evaluation of a brief self-completed family history screening tool for common chronic disease prevention in primary care. British Journal of General Practice 2013; DOI: 10.3399/bjgp13X668186. Walter FM, Prevost AT, Vasconcelos J, Hall PN, Burrows N, Kinmonth AL, Morris HC, Emery JD. Using the 7-point checklist as a diagnostic aid for pigmented skin lesions in general practice: a diagnostic validation study. British Journal of General Practice 2013; DOI: 10.3399/bjgp13X667213. Wilson ECF, Emery JD, Kinmonth AL, Prevost AT, Morris HC, Humphrys E, Hall PN. Burrows N, Bradshaw L, Walls J, Norris P, Johnson M, Walter F. The cost-effectiveness of a novel SIAscopic diagnostic aid for the management of pigmented skin lesions in primary care: a decision analytic model. Value in Health 2013;16:356-366. Walter FM, Morris HC, Humphrys E, Hall PN, Prevost AT, Burrows N, Bradshaw L, Wilson ECF, Norris P, Walls J, Johnson M, Kinmonth AL, Emery JD. Effect of adding a diagnostic aid to best practice to manage suspicious pigmented lesions in primary care: randomised controlled trial. BMJ 2012;344:e4110. Kadri SR, Lao-Sirieix P, O?Donovan M, Debiram I, Das M, Blazeby JM, Emery J, Boussioutas A, Morris H, Walter FM, Pharoah P, Hardwick RH, Fitzgerald RC. Acceptability and accuracy of a non-endoscopic screening test for Barrett?s oesophagus in primary care: cohort study. BMJ 2010:341:c4372. Walter FM, Morris HC, Humphrys E, Hall PN, Kinmonth AL, Prevost AT, Wilson E, Burrows N, Norris P, Johnson M, Emery J. Protocol for the MoleMateTM UK Trial: a randomised controlled trial of the MoleMate system in the management of pigmented skin lesions in primary care [ISRCTN 79932379]. BMC Family Practice 2010; 11:36. Watson T, Walter FM, Wood A, Morris H, Hall P, Karner S, Emery J. Learning a novel technique to identify possible melanomas: are Australian general practitioners better than their U.K. colleagues? Asia Pacific Family Medicine 2009, 8:3. Wood A, Morris H, Emery J, Hall P, Cotton S, Prevost AT, Walter FM. Evaluation of the MoleMateTM training program for assessment of suspicious pigmented lesions in primary care. Informatics in Primary Care 2008;16:41-50. Emery J, Morris H, Goodchild R, Fanshawe T, Prevost AT, Bobrow M, Kinmonth AL. The GRAIDS Trial: a cluster randomised controlled trial of computer decision support for the management of familial cancer in primary care. British Journal of Cancer 2007;97:486-493.